Anthelmintic Drugs Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

What industry-specific factors are fueling the growth of the anthelmintic drugs market?
The anthelmintic drugs market is anticipated to expand owing to the high occurrence of parasitic infections. These infections originate from organisms, like protozoa, worms, or ectoparasites, that inhabit or live on another host. Factors such as poor sanitation, contaminated resources, insufficient hygiene, close interaction with infected persons or animals, and a shortage of access to clean resources fuel the prevalence of parasitic infections. Anthelmintic drugs, geared to manage infections by parasitic worms, operate by interrupting the physiological functions of these parasites, facilitating their elimination or death. For example, the Centers for Disease Control and Prevention reported a twofold increase in cases of cyclosporiasis, caused by a microscopic parasite, in Florida in July 2023. These cases surged from 254 in 2021 to 513 in 2022. As such, the escalation in parasitic infections is catalyzing the growth of the anthelmintic drugs market.

Get Your Anthelmintic Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report

What Is the projected market size and growth rate for the anthelmintic drugs market?
The market size for anthelmintic drugs has seen a robust growth over the previous years. It is projected to expand from $3.16 billion in 2024 to $3.34 billion in 2025, registering a compound annual growth rate (CAGR) of 5.6%. The growth observed in the historic period is due to factors such as the high frequency of helminth infections, surge in public health initiatives, increase in research and development in the pharmaceutical sector, enhanced awareness and education, and economic development.

The market for anthelmintic drugs is set to experience robust expansion in the upcoming years, projected to reach $4.11 billion by 2029, rising at a compound annual growth rate (CAGR) of 5.3%. This projected growth for the forecast period is due in part to the global rise in parasitic infections, increased usage of anthelmintics for livestock and pet care, heightened public awareness, and health initiatives, along with the growth in international travel. Key trends that are anticipated to shape the market during the forecast period encompass the growing demand for combination treatments, an enhanced focus on managing drug resistance, the rise in the adoption of personalized medicine, the proliferation of telemedicine in treatment monitoring, increased research into new drug targets, and the prioritization of preventive healthcare methods.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19291&type=smp

What new trends are reshaping the anthelmintic drugs market and its opportunities?
The focus of leading players in the anthelmintic drugs market is on advancing innovative combination drugs that provide broad-ranging protection against multiple parasites. These combination anthelmintic drugs are concoctions of two or more anthelmintic components that augment their potency against parasitic infections, applicable to both humans and animals. They function in a synergistic manner to widen the scope of activity and slow down drug resistance development, besides counteracting existing parasite resistance patterns. For example, in January 2022, Zoetis Inc., an American animal health company, attained approval from the U.S. Food and Drug Administration for a new label indication for Simparica Trio, which effectively prevents infections instigated by Borrelia burgdorferi, the causative organism for canine Lyme disease. Simparica Trio merges three potent components, namely sarolaner, moxidectin and pyrantel, offering thorough protection against fleas, ticks, heartworms, roundworms and hookworms.

What major market segments define the scope and growth of the anthelmintic drugs market?
The anthelmintic drugsmarket covered in this report is segmented -

1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes
2) By Route Of Administration: Oral, Injectable
3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections
4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores
5) By Application: Human Anthelmintics, Veterinary Anthelmintics

Subsegments:
1) By Benzimidazoles: Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole
2) By Macrocyclic Lactones: Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime
3) By Pyrazinoisoquinolones: Praziquantel, Cysticide
4) By Tetrahydropyrimidines: Pyrantel Pamoate, Pyrantel Tartrate
5) By Other Drug Classes: Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19291

Which region dominates the anthelmintic drugs market?
North America was the largest region in the anthelmintic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the anthelmintic drugs industry growth?
Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals, Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=19291&type=smp

What Is Covered In The Anthelmintic Drugs Global Market Report?

•Market Size Forecast: Examine the anthelmintic drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the anthelmintic drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the anthelmintic drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the anthelmintic drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the anthelmintic drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the anthelmintic drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the anthelmintic drugs market.
•Competitive Landscape: Review strategic developments in the anthelmintic drugs market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.